Regulated Information

41 results have been found

Advanced search
Categories
Years
Number of results
1 2 3 4 5 | »
Press releases

DBV Technologies Announces ToplineResults of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

Outstanding shares and voting rights statements | Press releases

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut

Outstanding shares and voting rights statements | Press releases

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

DBV Technologies to Attend Upcoming Investor Conferences

Press releases

DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut

Outstanding shares and voting rights statements | Press releases

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age 

Press releases

DBV Technologies Reports First Half 2017 Financial Results

Half-year financial reports

Half Year Financial Report 2017

1 2 3 4 5 | »